Roles of long non-coding RNAs in colorectal cancer tumorigenesis: A Review

• Published in: Molecular and clinical oncology Vol. 11; no. 2; pp. 167 - 172
• Main Authors: Siddiqui, Halima, Al-Ghafari, Ayat, Choudhry, Hani, Al Doghaither, Huda
• Format: Journal Article
• Language: English
• Published: England Spandidos Publications 01.08.2019; Spandidos Publications UK Ltd; D.A. Spandidos
• Subjects: Biochemistry; Biological markers; Cancer diagnosis; Cancer patients; Cancer research; Cell growth; Colorectal cancer; Epigenetics; Gene expression; Genes; Kinases; Medical diagnosis; Medical prognosis; Medical research; Mortality; Novels; Nucleic acids; Oncology; Prognosis; Tumors; diagnosis; colorectal cancer; long non-coding RNAs; prognosis; biomarkers
• ISSN: 2049-9450; 2049-9469
• DOI: 10.3892/mco.2019.1872

Long non-coding RNAs (lncRNAs) are newly identified potential biological and gene regulators. Similar to other cell-free circulating cancer-related nucleic acids, lncRNAs are released in the peripheral circulation of cancer patients and allow for non-invasive gene expression assessment. lncRNAs are considered to be promising biomarkers for cancer prognosis and diagnosis. Several lncRNAs have been found to regulate developmental processes in a number of biological disorders. Recent studies indicated that lncRNAs are associated with numerous diseases, most notably cancer, as they were found to be highly expressed or silenced in a number of human cancers, including colorectal cancer (CRC). Despite advances in the current detection methods, over half of cancer patients succumb to the disease, as several CRC cases are diagnosed at an advanced stage. Due to the lack of non-invasive and low-cost prognostic and diagnostic tests for CRC, the identification of novel, potentially effective biomarkers has been attracting increasing attention in recent cancer research. The present review focused on the most widely applied lncRNAs in cancer detection, including CRC, .